Isis Announces That ISIS-TTR Rx Has Been Granted Fast Track Designatio
- ICU
- 17/12/2012
Isis Pharmaceuticals, Inc. announced on 13 December that the US Food and Drug Administration (FDA) has granted ISIS-TTR Rx fast track designation for the treatment of familial amyloid poly
READ MORE